1 results match your criteria: "417 Share Army Fund Hospital[Affiliation]"

In this editorial, we comment on the article by Lyu published in the recent issue of the (2023; 2219-2840). Hepatocellular carcinoma (HCC) is a frequently encountered and highly aggressive primary liver cancer, which remains the third-commonest cause of cancer-related death despite the current therapeutic modalities. There is urgency in developing novel therapeutic approaches, such as by manipulating extracellular vesicles, which constitute a highly heterogeneous nanoparticle population that contains various cargoes.

View Article and Find Full Text PDF